| Views | |
|---|---|
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing | 992 |
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing | 1 | 3 | 21 | 8 | 2 | 0 | 0 |
| Views | |
|---|---|
| artconlli_a2015_noguera_julian_low_frequency_drug_resistant.pdf | 6 |
| Views | |
|---|---|
| United States | 552 |
| Sweden | 99 |
| Germany | 57 |
| France | 39 |
| Ukraine | 37 |
| China | 29 |
| Russia | 26 |
| Spain | 22 |
| United Kingdom | 22 |
| Canada | 10 |
| Views | |
|---|---|
| Ashburn | 114 |
| Ann Arbor | 55 |
| Sunnyvale | 53 |
| Fairfield | 52 |
| Oakland | 31 |
| Mountain View | 28 |
| Beijing | 24 |
| Cambridge | 19 |
| Houston | 19 |
| Woodbridge | 15 |